AG Sessions to Congress: Kill medical marijuana protections

U.S. Attorney General Jeff Sessions asked four congressional leaders at the beginning of May to omit key medical marijuana industry protections from a new federal spending bill.

Although the attempt was unsuccessful, the letter – first reported by cannabis-focused social media platform MassRoots – underscores that marijuana businesses are not yet totally safe from possible federal intervention.

Sessions specifically asked that language from the Rohrabacher-Farr Amendment not be included in any appropriations bill, or similar provisions, that would “in any way inhibit the (Department of Justice’s) authority to enforce the Controlled Substances Act.”

The amendment, first approved in 2014, bars the DOJ from spending federal funds to interfere with the implementation of state medical marijuana laws.

Language from the amendment was included in a spending bill in early May, but the measure is set to expire at the end of September if not renewed by Congress. The amendment essentially guarantees MMJ companies that are compliant with state laws are safe from raids or prosecution by the Drug Enforcement Administration. It does not apply to recreational cannabis businesses.

Nicole L’Esperance, press secretary for U.S. Rep. Earl Blumenauer, D-Oregon, confirmed the authenticity of the letter to Marijuana Business Daily. 

She also said Blumenauer – a member of the Congressional Cannabis Caucus – remains confident the MMJ industry protection will survive attempts by Sessions to kill it because of the “broad bipartisan support” for the measure within Congress.

L’Esperance also said the letter wasn’t necessarily an indicator of a larger anti-cannabis policy agenda within the Trump administration because the president hasn’t clearly outlined a specific stance on marijuana.

“It’s definitely something to be alert to, but when you look at this administration, it’s constant whiplash,” she said. “They say one thing and do another … so it’s hard to take one action as an indication of a broader policy issue.”

A spokesman for U.S. Rep. Dana Rohrabacher, R-California, told The Washington Post that “Sessions stands athwart an overwhelming majority of Americans and even, sadly, against veterans and other suffering Americans who we now know conclusively are helped dramatically by medical marijuana.”

Daily News | Briefs | Election News | Legal & Regulatory News for Marijuana Businesses | National Medical Cannabis Business & Marijuana Legal News

 16 Comments

  1. 4trumpsessions June 13, 2017
    • jason June 13, 2017
    • Cactus Bill June 13, 2017
    • NOT4trumpsessions June 15, 2017
  2. john h davis June 13, 2017
  3. Rick Fague June 13, 2017
  4. Steve Hackenberg June 13, 2017
    • FK506 June 13, 2017
      • Educate thyself June 14, 2017
  5. Ed Smith June 13, 2017
  6. Bill lewis June 13, 2017
  7. RB June 13, 2017
  8. Tony Russo June 13, 2017
  9. Paul Sorensen June 13, 2017
  10. Farah June 14, 2017
    • Cactus Bill June 14, 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

Please note: Comments are moderated by our editors who do their best to approve comments ASAP. As Marijuana Business Daily is focused on business, we approve comments that are specifically relevant to industry professionals. General opinions and questions about cannabis may not be posted.